Milestone Achievement Program – MAP

Program Overview

The Milestone Achievement Program (MAP) is designed to address the needs of early-stage life sciences companies by providing grant funding to execute critical, value-creating technical milestones. This program aims to fill a gap within the existing funding environment to enable early stage companies to attract additional follow on funding.  The Massachusetts Life Sciences Center recognizes that many innovative companies are a milestone away from reaching an inflection point to further the success of the technology, and advance the company overall.

Up to $2M in funding is available for this program year. The highly competitive MAP will provide awards of up to $200,000 in non-dilutive grant funding to Massachusetts companies who propose the completion of a technical milestone, which has been informed by investors and/or board members. Examples of fundable milestones may include: prototype development, technology assessments, manufacturing process, pre-clinical work, clinical trials, market analysis, competitive assessments, and regulatory strategy design.

Application and Review Process

MAP application period closed on December 14, 2018.

The MLSC manages the MAP award through a rigorous review process:

Upon submission of an online application, an administrative review will be conducted to ensure eligibility criteria has been met. Eligible applications will then proceed to the formal review process by a Scientific Advisory Board (SAB), which is comprised scientific and industry experts. High scoring ranked applicants may be asked questions for further clarification, prior to an in-person presentation to our SAB. Finalists will then move on for a review by the MLSC’s Investment Committee, who will have an opportunity to hear the companies present their proposal. Decisions will be made by the Center’s Board of Directors for approval by May 2019.

Questions

If you have further questions regarding the program, please email the Industry team at: map@masslifesciences.com

Connect With Us

Blog Facebook LinkedIn Twitter